You just read:

Nordic Nanovector: Single Administration Betalutin® is Effective and Well-tolerated in R/R iNHL Patients: 6 Month Follow-up Data Presented at ASH

News provided by

Nordic Nanovector

Dec 02, 2018, 22:12 ET